OPK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
OPKO Health Inc (OPK) is not a strong buy for a beginner, long-term investor at this time. The company is facing significant financial challenges, with declining revenue, net income, and EPS. While there is notable insider and hedge fund buying, the lack of positive news, bearish technical indicators, and concerning analyst commentary suggest caution. For a long-term strategy, this stock does not currently present a compelling opportunity.
The technical indicators are bearish. The MACD is slightly positive but contracting, RSI is neutral at 38.432, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 1.193, with key support at 1.143 and resistance at 1.242.
Insider and hedge fund buying activity has increased significantly, with insiders increasing their buying by 1295.35% and hedge funds by 1498.79% over recent periods.
The company's financial performance in Q4 2025 was poor, with revenue down 19.16% YoY, net income down 322.83% YoY, and EPS down 300% YoY. Gross margin also declined by 13.51%. Analysts have lowered their price target, citing concerns about the sustainability of recent performance.
In Q4 2025, OPKO Health reported a revenue drop to $148.45M (-19.16% YoY), net income of -$31.26M (-322.83% YoY), EPS of -0.04 (-300% YoY), and gross margin of 30.29 (-13.51% YoY).
Barrington lowered the price target from $2.25 to $1.50, maintaining an Outperform rating but expressing concerns about the sustainability of the company's performance.
